J. Leßke

1.4k total citations
10 papers, 1.1k citations indexed

About

J. Leßke is a scholar working on Hepatology, Epidemiology and Endocrine and Autonomic Systems. According to data from OpenAlex, J. Leßke has authored 10 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hepatology, 4 papers in Epidemiology and 3 papers in Endocrine and Autonomic Systems. Recurrent topics in J. Leßke's work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Hepatitis B Virus Studies (3 papers) and Neuroscience of respiration and sleep (3 papers). J. Leßke is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Hepatitis B Virus Studies (3 papers) and Neuroscience of respiration and sleep (3 papers). J. Leßke collaborates with scholars based in Germany, United States and South Korea. J. Leßke's co-authors include Charles C. Miller, Eugene C. Fletcher, Thomas Unger, Wei Qian, Harald M. Stauss, Robert Behm, Juraj Čulman, Wolfgang E. Fleig, E. Lotterer and Jörg Albert and has published in prestigious journals such as Journal of Applied Physiology, Hypertension and Gastrointestinal Endoscopy.

In The Last Decade

J. Leßke

10 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Leßke Germany 7 829 648 278 275 273 10 1.1k
Paolo Bottini Italy 14 180 0.2× 296 0.5× 233 0.8× 128 0.5× 193 0.7× 18 846
Debby Nicoll United Kingdom 9 679 0.8× 1.0k 1.6× 149 0.5× 398 1.4× 17 0.1× 17 1.2k
Marta Forner Spain 7 490 0.6× 684 1.1× 79 0.3× 320 1.2× 16 0.1× 13 888
Sophie West United Kingdom 11 488 0.6× 744 1.1× 62 0.2× 234 0.9× 16 0.1× 22 920
Steen Löth Sweden 7 492 0.6× 707 1.1× 91 0.3× 368 1.3× 6 0.0× 10 799
Candela Caballero‐Eraso Spain 12 299 0.4× 246 0.4× 94 0.3× 146 0.5× 33 0.1× 46 493
G Casucci Italy 12 93 0.1× 169 0.3× 138 0.5× 101 0.4× 75 0.3× 19 583
Yi Xiao China 16 273 0.3× 368 0.6× 57 0.2× 254 0.9× 18 0.1× 95 762
María José Masdeu Spain 12 308 0.4× 558 0.9× 38 0.1× 326 1.2× 18 0.1× 29 690
P. R. Bender United States 10 250 0.3× 210 0.3× 215 0.8× 180 0.7× 505 1.8× 13 795

Countries citing papers authored by J. Leßke

Since Specialization
Citations

This map shows the geographic impact of J. Leßke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Leßke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Leßke more than expected).

Fields of papers citing papers by J. Leßke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Leßke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Leßke. The network helps show where J. Leßke may publish in the future.

Co-authorship network of co-authors of J. Leßke

This figure shows the co-authorship network connecting the top 25 collaborators of J. Leßke. A scholar is included among the top collaborators of J. Leßke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Leßke. J. Leßke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Dollinger, Matthias, Christine Lautenschlaeger, J. Leßke, et al.. (2010). Thymostimulin versus placebo for palliative treatment of locally advanced or metastasised hepatocellular carcinoma: a phase III clinical trial. BMC Cancer. 10(1). 457–457. 10 indexed citations
2.
Dollinger, Matthias, et al.. (2008). Thymostimulin in advanced hepatocellular carcinoma: A phase II trial. BMC Cancer. 8(1). 72–72. 4 indexed citations
3.
Albert, Jörg, et al.. (2004). Simethicone for small bowel preparation for capsule endoscopy: a systematic, single-blinded, controlled study. Gastrointestinal Endoscopy. 59(4). 487–491. 104 indexed citations
4.
Fleig, Wolfgang E., et al.. (2004). Indikationsstellung akute/chronische Hepatitis C. Zeitschrift für Gastroenterologie. 42(8). 707–713. 6 indexed citations
6.
Fleig, Wolfgang E. & J. Leßke. (2003). Hepatozelluläres Karzinom: Primär- und Sekundärprophylaxe sowie medikamentöse Therapie. Visceral Medicine. 19(3). 247–252. 3 indexed citations
7.
Leßke, J., et al.. (2002). Maligne Lebertumoren – Früherkennung und lokale Behandlung. Visceral Medicine. 18(2). 128–133. 1 indexed citations
8.
Fletcher, Eugene C., J. Leßke, Juraj Čulman, Charles C. Miller, & Thomas Unger. (1992). Sympathetic denervation blocks blood pressure elevation in episodic hypoxia.. Hypertension. 20(5). 612–619. 194 indexed citations
9.
Fletcher, Eugene C., J. Leßke, Robert Behm, et al.. (1992). Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. Journal of Applied Physiology. 72(5). 1978–1984. 368 indexed citations
10.
Fletcher, Eugene C., J. Leßke, Wei Qian, Charles C. Miller, & Thomas Unger. (1992). Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats.. Hypertension. 19(6_pt_1). 555–561. 390 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026